AU2013315484A1 - Anti-pain and anti-nausea and/or vomiting combinatorial compositions - Google Patents

Anti-pain and anti-nausea and/or vomiting combinatorial compositions Download PDF

Info

Publication number
AU2013315484A1
AU2013315484A1 AU2013315484A AU2013315484A AU2013315484A1 AU 2013315484 A1 AU2013315484 A1 AU 2013315484A1 AU 2013315484 A AU2013315484 A AU 2013315484A AU 2013315484 A AU2013315484 A AU 2013315484A AU 2013315484 A1 AU2013315484 A1 AU 2013315484A1
Authority
AU
Australia
Prior art keywords
film
drug delivery
delivery system
active component
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013315484A
Other languages
English (en)
Inventor
Daniel Barber
Eric Dadey
Garry Myers
Mark Schobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aquestive Therapeutics Inc
Original Assignee
MonoSol Rx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MonoSol Rx LLC filed Critical MonoSol Rx LLC
Publication of AU2013315484A1 publication Critical patent/AU2013315484A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2013315484A 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions Abandoned AU2013315484A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261700146P 2012-09-12 2012-09-12
US61/700,146 2012-09-12
US13/843,718 2013-03-15
US13/843,718 US20140073678A1 (en) 2012-09-12 2013-03-15 Anti-pain and anti-nausea and/or vomiting combinatorial compositions
PCT/US2013/059460 WO2014043346A2 (en) 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions

Publications (1)

Publication Number Publication Date
AU2013315484A1 true AU2013315484A1 (en) 2015-04-09

Family

ID=50233885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013315484A Abandoned AU2013315484A1 (en) 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions

Country Status (6)

Country Link
US (1) US20140073678A1 (enExample)
EP (1) EP2895145A2 (enExample)
JP (1) JP2015528504A (enExample)
AU (1) AU2013315484A1 (enExample)
CA (1) CA2884757A1 (enExample)
WO (1) WO2014043346A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US20140275194A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Films and drug delivery systems for rizatriptan
AU2015280262B2 (en) 2014-06-24 2020-08-13 Taho Pharmaceuticals Ltd. Fast acting orally disintegrating film
RU2017111887A (ru) * 2014-09-09 2018-10-11 Чарлстон Лэбораториз, Инк. Фармацевтические композиции
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
IL270654B2 (en) 2017-05-17 2024-07-01 Confluence Pharmaceuticals Llc Formulations of homotaurines and salts thereof
WO2019069123A1 (en) * 2017-10-07 2019-04-11 Zim Laboratories Ltd. METHOD FOR PREPARING A BI OR MULTILAYER FILM, MULTILAYER FILM PRODUCED THEREFROM, AND APPARATUS FOR PRODUCING SUCH MULTILAYER FILMS
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2022104234A1 (en) * 2020-11-15 2022-05-19 Castor Trevor P Methods for assaying and measuring the efficacy of anti-nausea compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1246668B1 (en) * 1999-12-01 2005-11-30 Natco Pharma Limited An rapid acting freeze dired oral pharmaceutical composition for treating migraine
EP1863454A2 (en) * 2005-03-28 2007-12-12 Orexo AB New pharmaceutical compositions useful in the treatment of migraine
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
US8580830B2 (en) * 2006-10-02 2013-11-12 Labtec Gmbh Non-mucoadhesive film dosage forms
ES2604968T3 (es) * 2008-04-28 2017-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
ES2699077T3 (es) * 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
EP3311667A1 (en) * 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CN102028672B (zh) * 2010-09-29 2012-08-29 上海现代药物制剂工程研究中心有限公司 微孔海绵状药膜制剂及其制备方法

Also Published As

Publication number Publication date
WO2014043346A3 (en) 2014-07-31
CA2884757A1 (en) 2014-03-20
US20140073678A1 (en) 2014-03-13
WO2014043346A2 (en) 2014-03-20
EP2895145A2 (en) 2015-07-22
JP2015528504A (ja) 2015-09-28

Similar Documents

Publication Publication Date Title
US20140073678A1 (en) Anti-pain and anti-nausea and/or vomiting combinatorial compositions
US20230138361A1 (en) Enhanced delivery epinephrine compositions
US9855221B2 (en) Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8840919B2 (en) Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
CN100356908C (zh) 具有非自聚集一致不均匀性的薄膜及由其制造的给药系统
JP5717946B2 (ja) ポリビニルアルコール−ポリエチレングリコールグラフト共重合体を含有する泡状ウェハ
CZ20012566A3 (cs) Jednotková dávka a způsob přípravy jednotkové dávky pro slizniční podávání
BR112013015204A2 (pt) composição farmacêutica em forma de unidade de dosagem formulada para administração sublingual e uso da referida composição
CN101668519A (zh) 聚合物基薄膜以及由其制备的药物递送系统
JP2009518405A (ja) 活性物質の送達のための局所フィルム組成物
CN103298459A (zh) 用于直接在包装表面上形成药用产品的方法和系统
JP2010515761A (ja) 高用量フィルム組成物およびその製法
CA2621263A1 (en) Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
CN101516331A (zh) 含有抗泡沫调味剂的可食用水溶性膜
JP2017537127A (ja) 線状多糖をベースとするフィルム製品
JPS58213709A (ja) 歯肉粘膜用貼付剤
EP4058029B1 (en) Multimodal compositions and methods of treatment
JP2009521532A (ja) 活性物質を放出するための、ｐＨ調節されたフィルム
JP2024543149A (ja) 経口マイクロニードルパッチ
Chauhan et al. A comprehensive review on mucoadhesive drug delivery
EP2889030A1 (en) Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels
Sinha et al. Oral soluble films: attributes of the polymeric material and critical process parameters for designing good quality films
CA2906050C (en) Films and drug delivery systems for rizatriptan
Repka et al. Buccal drug delivery
Paul et al. EXPLORING THE POTENTIAL OF FAST DISSOLVING ORAL FILMS

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period